List of Released Research Collaborations

Year Partner Organization Collaboration Overview
2022 LPIXEL Comprehensive alliance
2020 Gustave Roussy Research collaboration
2020 Nagoya Institute of Technology, Mitsubishi UFJ Capital  Establishment of and investment in a new company
2020 Ultragenyx Pharmaceutical Research collaboration
2019 Tokyo Institute of Technology, Mitsubishi UFJ Capital  Establishment of and investment in a new company
2018 Keio University, Kochi University, National Institutes of Biomedical Innovation, Health and Nutrition, Ono Pharmaceutical, Mitsubishi Tanabe Pharma Launch of immune-mediated inflammatory diseases consortium
2018 Zymeworks Research collaboration
2018 DarwinHealth Research collaboration
2018 Nagoya city university, Chubu university, Mitsubishi UFJ Capital Establishment of and investment in a new company
2017 Puma Biotechnology, Memorial Sloan Kettering Cancer Center Research collaboration
2017 Glycotope Research collaboration
2017 Astellas Pharma, Mitsubishi Tanabe Pharma Collaboration on drug-repositioning compound libraries
2017 MD Anderson Cancer Center Research collaboration
2017 Max Planck Innovation, the Lead Discovery Center Research collaboration
2017 National Institutes of Biomedical Innovation, Health and Nutrition, Mitsubishi UFJ Capital Establishment of and investment in a new company
2017 Heptares Therapeutics Research collaboration
2016 Astellas Pharma, Takeda Pharmaceutical Collaboration on fundamental biomarker
2016 Asahikawa Medical University, Mitsubishi UFJ Capital  Establishment of and investment in a new company
2016 The National Cancer Center, The University of Tokyo Co-Development of new molecular targeting drug
2015 University of Tokyo Providing compound libraries
2014 Sanford-Burnham Medical Research Institute Research collaboration
2014 University of California, San Francisco Research collaboration
2014 Astellas Pharma Compound library partnership
2014 UMN Pharma Research collaboration
2014 Virtici, Celdara Medical Research collaboration

Please direct your inquiries and/or proposals to